✦ LIBER ✦

Induction immunosuppression with interleukin-2 receptor antibodies (basiliximab and daclizumab) in renal transplant recipients

✍ Scribed by M.P Nair; M.R.N Nampoory; K.V Johny; J.N Costandi; M Abdulhalim; W El-Reshaid; I Al-Muzairai; V.T Ninan; M Samhan; M Al-Mousawi

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Interleukin-2 receptor antagonist induct

✍ Flavio Vincenti; Amado De Andrés; Thomas Becker; Gabriel Choukroun; Edward Cole; 📂 Article 📅 2006 🏛 Springer 🌐 English ⚖ 135 KB

Comparison of Basiliximab and Daclizumab

✍ S. Aktas; T. Colak; E. Baskin; S. Sevmis; H. Ozdemir; G. Moray; H. Karakayali; M 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 135 KB

Daclizumab induction therapy in liver tr

✍ S. K. Asrani; W. R. Kim; R. A. Pedersen; M. R. Charlton; W. K. Kremers; T. M. Th 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 475 KB

IL2-receptor antagonist (basiliximab) in

✍ B.Y. Choy; T.M. Chan; F.K. Li; S.L. Lui; W.K. Lo; T. Yip; K.C. Tse; K.N. Lai 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 45 KB

Use of daclizumab as initial immunosuppr

✍ Sukru Emre; Gabriel Gondolesi; Kamil Polat; Menahem Ben-Haim; Tarik Artis; Thoma 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 210 KB

Experimental Isolation and Transplantati

✍ I. Tsiolis; A. Papalois; I. Loukopoulos; A. Gravvanis; E. Lykoudis; E. Theodosso 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 51 KB